COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients

Conditions:   Moderate COVID-19 Pneumonia, Severe COVID-19 Pneumonia;   Pneumonia, Viral Intervention:   Drug: COVID-19 Convalscent Plasma Sponsor:   Ministry of Health, Kuwait Recruiting

Source: ClinicalTrials.gov - July 16, 2020 Category: Research Source Type: clinical trials